Development of dengue virus tetravalent NS1 and E vaccine using the Herpes Simplex Virus delta-g(GJDI)-2 vector
Closed Special Notice Posted
- Solicitation number
- 1301017463
- Agency
-
Naval Supply Systems Command
Department of the Navy, Department of Defense
- Responses due
- Set-aside
- No set-aside
Opportunity facts
- NAICS code
- 541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
- PSC
- AN25 Health R&D Services; Health Research And Training; Expenses For R&D Facilities And Major Equipment
- Place of performance
- Silver Spring, Maryland 20910, United States
Notice details come from SAM.gov. Updated .
Notice text
The United States Department Of Naval Medical Research Center(NMRC) intends to award a sole source contract, to, Albert Einstein College Of Medicine. Bronx, NY. 10461. This notice is not a request for competitive proposals however If interested Government shall consider all responses.
The NAICS code for this action is 541715. This requirement will be procured under the guidelines of FAR Part 12 Commercial Items. NMRC requires that all contractors doing business with the Acquisition Office must be registered with the Systems For Award Management (SAM). No award can be made unless the vendor is registered in Systems For Award Management. For additional information and to register in SAM, please access the following website: http://www.sam.gov/. In order to register with the SAM and to be eligible to receive an award from this Acquisition Office, all offers must have a DUN & Bradstreet Number. A Dun & Bradstreet number may be acquired free of charge by contacting Dun & Bradstreet online at https://www.dnb.com/products/eupdate/requestOptions.html or by phone at (800) 333-0505
This contract will be for the Development of dengue virus tetravalent NS1 and E vaccine using the Herpes Simplex Virus delta-g(GJDI)-2 vect. See attached Statement Of Work for details.
1. Materials and Supplies, Qty/12mos.
2. Animal Cost, Qty/ 12mos.
3. Salaries/Benefit, Qty/ 12mos.
4. Indirect cost MTDC, Qty/ 12mos.
Files
| File | Type | Posted |
|---|---|---|
| Statement of Work_NS1_ADCC_vaccine 04082022.docx | DOCX document | |
| AECOM Sole Source Justification 03092022.WRJ_Final_Rd.pdf |
On GovTribe
Work this opportunity
- Track it in your pipeline
- Find teaming partners
- Similar opportunities
- Ask GovTribe AI about this opportunity